Rossari Biotech Net Income vs. Gross Profit
| ROSSARI Stock | 826.15 18.40 2.18% |
Net Income | First Reported 2019-06-30 | Previous Quarter 349 M | Current Value 353.3 M | Quarterly Volatility 66.8 M |
For Rossari Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Rossari Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Rossari Biotech Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Rossari Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Rossari Biotech Limited over time as well as its relative position and ranking within its peers.
Rossari |
Rossari Biotech Gross Profit vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Rossari Biotech's current stock value. Our valuation model uses many indicators to compare Rossari Biotech value to that of its competitors to determine the firm's financial worth. Rossari Biotech Limited is currently regarded as top stock in net income category among its peers. It also is currently regarded as top stock in gross profit category among its peers fabricating about 2.86 of Gross Profit per Net Income. As of now, Rossari Biotech's Net Income is increasing as compared to previous years. Comparative valuation analysis is a catch-all model that can be used if you cannot value Rossari Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rossari Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Rossari Gross Profit vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Rossari Biotech |
| = | 1.31 B |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Rossari Biotech |
| = | 3.74 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Rossari Gross Profit Comparison
Rossari Biotech is currently under evaluation in gross profit category among its peers.
Rossari Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Rossari Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Rossari Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Rossari Biotech's change in net profit over the period of time. It can combine multiple indicators of Rossari Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 35.4 M | 28.4 M | |
| Operating Income | 1.8 B | 1.1 B | |
| Income Before Tax | 1.8 B | 1.1 B | |
| Total Other Income Expense Net | -51 M | -53.6 M | |
| Net Income Applicable To Common Shares | 1.1 B | 602.3 M | |
| Net Income | 1.3 B | 991.1 M | |
| Income Tax Expense | 469.3 M | 283.3 M | |
| Net Interest Income | -193.7 M | -184 M | |
| Interest Income | 29 M | 24.9 M | |
| Net Income From Continuing Ops | 1.3 B | 867.5 M | |
| Change To Netincome | -30.4 M | -28.9 M |
Rossari Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Rossari Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Rossari Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Rossari Biotech's important profitability drivers and their relationship over time.
Use Rossari Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rossari Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will appreciate offsetting losses from the drop in the long position's value.Rossari Biotech Pair Trading
Rossari Biotech Limited Pair Trading Analysis
The ability to find closely correlated positions to Rossari Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rossari Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rossari Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rossari Biotech Limited to buy it.
The correlation of Rossari Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rossari Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rossari Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rossari Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Rossari Biotech position
In addition to having Rossari Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Printing and Publishing Thematic Idea Now
Printing and Publishing
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Rossari Stock
To fully project Rossari Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Rossari Biotech's income statement, its balance sheet, and the statement of cash flows.